Pure Global

Clinical chemistry toxicology/drug detection IVDs - ARTG 425210

Access comprehensive regulatory information for Clinical chemistry toxicology/drug detection IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 425210 and sponsored by Natraplas Pty Ltd, manufactured by Hangzhou Alltest Biotech Co Ltd (China) in China. The device registration started on October 12, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
ARTG 425210
Class IIa
Clinical chemistry toxicology/drug detection IVDs
ARTG ID: 425210
Good Name: Natraplas Pty Ltd - Clinical chemistry toxicology/drug detection IVDs
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

IVDs intended to detect drugs and or drug metabolites in laboratory or point of care settings.

Device Classification
Risk Class
Class IIa
Product Type
IVD
ARTG Category
IVD
Registration Information
ARTG ID
425210
Start Date
October 12, 2023
Effective Date
November 06, 2023
Manufacturer
Country
China
Address
550# Yinhai Street Hangzhou Economic and Technological Development Area, Hangzhou, 310018